Table 1 Population description for the KB and IGR hospitals and association between variables measured at admission and severity.
KB, N = 837 | IGR, N = 150 | Pooled | ||||||
|---|---|---|---|---|---|---|---|---|
Distribution | Odds ratio | p-value association with severity | Distribution | Odds ratio | p-value association with severity | Pooled p-value | Significant association | |
Outcomes | ||||||||
Severity: “Intubation” OR “O2 ≥ 15 L” OR “Death” | 30% [817] | – | 32% [144] | – | – | |||
Intubation | 13% [837] | – | 11% [150] | – | – | |||
O2 ≥ 15 L | 15% [837] | – | 11% [150] | – | – | |||
Death | 17% [837] | – | 17% [150] | – | – | |||
Clinical characteristics | ||||||||
Age | 63.0 (52.0, 77.0) [833] | 1.61 (1.37, 1.90) | 7.32 × 10−09 | 6.10 (49.0, 71.0) [149] | 1.35 (0.92, 1.98) | 1.29 × 10−01 | 2.54 × 10−09 | Yes |
Sex | 57% [837] | 1.97 (1.43, 2.72) | 3.03 × 10−05 | 49% [150] | 1.07 (0.51, 2.23) | 8.67 × 10−01 | 3.52 × 10−05 | Yes |
BMI | 27.0 (23.5, 31.1) [400] | 1.17 (0.95, 1.43) | 1.39 × 10−01 | 24.9 (21.5, 27.7) [108] | 1.28 (0.81, 2.00) | 2.87 × 10−01 | 1.00 × 10−01 | |
Height | 1.7 (1.6, 1.8) [404] | 1.18 (0.96, 1.46) | 1.13 × 10−01 | 1.7 (1.6, 1.8) [109] | 1.08 (0.69, 1.71) | 7.30 × 10−01 | 1.05 × 10−01 | |
Weight | 75.0 (62.0, 90.0) [543] | 1.08 (0.91, 1.29) | 3.84 × 10−01 | 72.0 (60.0, 85.0) [119] | 1.31 (0.86, 1.99) | 2.06 × 10−01 | 2.81 × 10−01 | |
Clinical examination | ||||||||
Oxygen saturation | 95.0 (90.0, 97.0) [783] | 0.37 (0.30, 0.45) | 6.42 × 10−20 | 97.0 (94.0, 99.0) [132] | 0.35 (0.20, 0.63) | 4.33 × 10−04 | 7.32 × 10−22 | Yes |
Diastolic pressure | 80.0 (69.0, 90.0) [769] | 0.70 (0.60, 0.83) | 3.93 × 10−05 | 78.0 (69.0, 84.8) [138] | 0.75 (0.51, 1.11) | 1.55 × 10−01 | 1.74 × 10−05 | Yes |
Respiratory rate | 25.0 (20.0, 30.0) [667] | 1.33 (1.12, 1.58) | 1.10 × 10−03 | 22.0 (18.0, 28.0) [67] | 3.37 (1.28, 8.86) | 1.39 × 10−02 | 2.70 × 10−04 | Yes |
Systolic pressure | 134.0 (118.0, 148.0) [769] | 0.82 (0.70, 0.97) | 1.84 × 10−02 | 125.0 (113.5, 137.5) [139] | 0.74 (0.50, 1.10) | 1.37 × 10−01 | 9.87 × 10−03 | |
Cardiac frequency | 95.0 (82.0, 107.0) [771] | 0.94 (0.80, 1.10) | 4.29 × 10−01 | 90.0 (80.0, 102.2) [136] | 1.27 (0.86, 1.87) | 2.33 × 10−01 | 5.68 × 10−01 | |
Body temperature | 37.8 (37.0, 38.5) [788] | 0.99 (0.84, 1.17) | 9.28 × 10−01 | 37.3 (36.7, 38.0) [137] | 6.09 (0.97, 38.36) | 5.44 × 10−02 | 8.07 × 10−01 | |
Symptoms | ||||||||
Dyspnea | 68% [837] | 1.73 (1.23, 2.45) | 1.87 × 10−03 | 57% [150] | 1.67 (0.78, 3.59) | 1.88 × 10−01 | 9.93 × 10−04 | |
Chest pain | 8.2% [837] | 0.27 (0.12, 0.61) | 1.54 × 10−03 | 5.3% [150] | 0.78 (0.15, 4.04) | 7.68 × 10−01 | 1.52 × 10−03 | |
Myalgia | 24% [837] | 0.59 (0.41, 0.86) | 6.20 × 10−03 | 13% [150] | 0.99 (0.32, 3.01) | 9.83 × 10−01 | 6.95 × 10−03 | |
Confusion | 9.4% [837] | 1.73 (1.06, 2.81) | 2.80 × 10−02 | 2.7% [150] | 7.62 (0.77, 75.63) | 8.28 × 10−02 | 1.37 × 10−02 | |
Coughing | 41% [837] | 0.78 (0.57, 1.06) | 1.10 × 10−01 | 31% [150] | 0.88 (0.40,1.97) | 7.64 × 10−01 | 1.04 × 10−01 | |
Diarrhea | 8.0% [837] | 1.30 (0.76, 2.24) | 3.42 × 10−01 | 6.0% [150] | 1.20 (0.21, 6.82) | 8.39 × 10−01 | 3.31 × 10−01 | |
Fever | 51% [837] | 1.11 (0.82, 1.50) | 4.98 × 10−01 | 37% [150] | 1.53 (0.71, 3.26) | 2.75 × 10−01 | 3.92 × 10−01 | |
Asthenia | 17% [837] | 0.78 (0.51, 1.18) | 2.41 × 10−01 | 8.0% [150] | 3.18 (0.91, 11.09) | 7.01 × 10−02 | 4.01 × 10−01 | |
Symptoms duration before examination | 6.0 (3.0, 9.0) [771] | 1.02 (0.87, 1.19) | 8.13 × 10−01 | 4.0 (2.0, 7.8) [126] | 1.15 (0.78, 1.68) | 4.76 × 10−01 | 7.21 × 10−01 | |
Dry quintuous cough | 33% [837] | 0.95 (0.69, 1.31) | 7.43 × 10−01 | 20% [150] | 1.23 (0.48, 3.17) | 6.62 × 10−01 | 8.05 × 10−01 | |
Headache | 5.3% [837] | 1.09 (0.57, 2.09) | 8.04 × 10−01 | 3.3% [150] | 0.58 (0.06, 5.39) | 6.35 × 10−01 | 8.72 × 10−01 | |
Comorbidities and smoking | ||||||||
Chronic kidney disease | 12% [837] | 2.39 (1.54, 3.70) | 9.51 × 10−05 | 7.3% [150] | 16.59 (1.93, 142.84) | 1.06 × 10−02 | 1.81 × 10−05 | Yes |
Hypertension | 45% [837] | 1.77 (1.31, 2.40) | 2.43 × 10−04 | 35% [150] | 1.11 (0.51, 2.42) | 7.9 × 10−01 | 2.52 × 10−04 | Yes |
Asthma | 8.7% [837] | 0.41 (0.21, 0.80) | 8.87 × 10−03 | 6.0% [150] | 0.32 (0.04, 2.71) | 2.97 × 10−01 | 5.81 × 10−03 | |
Cardiac disease | 22% [837] | 1.41 (0.99, 2.02) | 5.77 × 10−02 | 17% [150] | 1.05 (0.39, 2.78) | 9.26 × 10−01 | 5.94 × 10−02 | |
Diabetes | 24% [837] | 1.32 (0.94, 1.87) | 1.13 × 10−01 | 19% [150] | 2.10 (0.83, 5.30) | 1.15 × 10−01 | 6.66 × 10−02 | |
Smoker | 15% [837] | 1.32 (0.87, 2.00) | 1.88 × 10−01 | 25% [150] | 2.85 (1.26, 6.44) | 1.17 × 10−02 | 8.30 × 10−02 | |
Emphysema | 6.0% [837] | 1.47 (0.80, 2.71) | 2.12 × 10−01 | 14% [150] | 4.12 (1.51, 11.25) | 5.62 × 10−03 | 8.73 × 10−02 | |
Corticosteroids | 3.9% [837] | 0.61 (0.26, 1.43) | 2.57 × 10−01 | 12% [150] | 3.14 (1.05, 9.37) | 3.99 × 10−02 | 4.48 × 10−01 | |
Chemotherapy | 1.0% [837] | 1.39 (0.33, 5.88) | 6.50 × 10−01 | 39% [150] | 1.88 (0.89, 3.98) | 9.94 × 10−02 | 4.64 × 10−01 | |
Dyslipidemia | 16% [837] | 1.09 (0.73, 1.65) | 6.71 × 10−01 | 11% [150] | 2.67 (0.87, 8.18) | 8.65 × 10−02 | 4.74 × 10−01 | |
NSAI | 3.6% [837] | 1.23 (0.56, 2.68) | 6.05 × 10−01 | 0.7% [150] | 0 (0, lnf) | 9.88 × 10−01 | 6.13 × 10−01 | |
Cancer | 7.3% [837] | 1.17 (0.66, 2.08) | 5.87 × 10−01 | 85% [150] | 0.47 (0.17, 1.30) | 1.45 × 10−01 | 7.78 × 10−01 | |
Biological measures | ||||||||
LDH | 341.0 (263.5, 452.5) [527] | 2.02 (1.63, 2.51) | 1.51 × 10−10 | 278.0 (203.8, 400.0) [134] | 2.36 (1.32, 4.21) | 3.77 × 10−03 | 9.78 × 10−12 | Yes |
Urea | 6.0 (4.2, 9.8) [739] | 1.66 (1.40, 1.97) | 5.72 × 10−09 | 5.1 (3.7, 6.9) [117] | 2.19 (1.36, 3.52) | 1.28 × 10−03 | 3.07 × 10−10 | Yes |
CRP | 69.0 (29.0, 130.0) [729] | 1.48 (1.27, 1.74) | 1.07 × 10−06 | 52.7 (15.1, 115.7) [142] | 1.48 (1.03, 2.14) | 3.64 × 10−02 | 2.37 × 10−07 | Yes |
Neutrophil | 5.0 (3.5, 7.1) [746] | 1.38 (1.18, 1.62) | 8.31 × 10−05 | 4.4 (2.3, 7.1) [148] | 1.15 (0.80, 1.64) | 4.51 × 10−01 | 6.16 × 10−05 | Yes |
Leukocytes | 6.7 (4.9, 9.0) [750] | 1.31 (1.12, 1.54) | 7.18 × 10−04 | 6.6 (4.1, 9.8) [144] | 1.19 (0.83, 1.71) | 3.43 × 10−01 | 4.73 × 10−04 | Yes |
Platelet | 206.0 (161.5, 259.5) [751] | 0.78 (0.66, 0.93) | 5.47 × 10−03 | 213.5 (156.0, 308.0) [144] | 0.76 (0.50, 1.15) | 1.93 × 10−01 | 3.06 × 10−03 | |
Ferritin | 627.0 (287.8, 1285.5) [296] | 1.27 (0.99, 1.62) | 6.33 × 10−02 | 567.0 (233.0, 1327.0) [125] | 1.52 (1.03, 2.26) | 3.70 × 10−02 | 2.85 × 10−02 | |
Total bilirubin | 8.0 (6.0, 11.0) [691] | 1.16 (0.99, 1.37) | 6.80 × 10−02 | 9.0 (6.0, 13.0) [137] | 1.52 (1.04, 2.23) | 3.25 × 10−02 | 3.01 × 10−02 | |
Conjugated bilirubin | 12.0 (9.0, 16.0) [57] | 1.32 (0.72, 2.42) | 3.63 × 10−01 | 2.0 (2.0, 5.0) [68] | 2.00 (1.10, 3.65) | 2.29 × 10−02 | 1.97 × 10−01 | |
Lymphocyte | 1.0 (0.7, 1.4) [745] | 0.89 (0.70, 1.12) | 3.16 × 10−01 | 1.0 (0.6, 1.6) [148] | 0.80 (0.53, 1.21) | 2.89 × 10−01 | 2.42 × 10−01 | |
Monocyte | 0.5 (0.3, 0.6) [746] | 0.93 (0.79, 1.10) | 3.99 × 10−01 | 0.5 (0.3, 0.8) [148] | 0.66 (0.36, 1.19) | 1.64 × 10−01 | 2.84 × 10−01 | |
Hemoglobin | 13.2 (12.1, 14.4) [751] | 1.06 (0.90, 1.24) | 4.84 × 10−01 | 11.1 (9.5, 12.8) [144] | 0.65 (0.43, 0.98) | 3.79 × 10−02 | 7.43 × 10−01 | |
Creatine kinase | 146.0 (84.0, 312.8) [638] | 0.98 (0.82, 1.18) | 8.47 × 10−01 | 70.5 (30.8, 157.2) [92] | 1.32 (0.83, 2.10) | 2.36 × 10−01 | 9.88 × 10−01 | |
Radiological standardized report | ||||||||
Disease extent 0/1/2/3/4/5 | 6.3/17/37/27/11/2.6% [806] | 2.43 (2.01, 2.93) | 2.13 × 10−20 | 14/36/24/7.2/10/8.7% [138] | 1.62 (1.11, 2.37) | 1.21 × 10−02 | 1.28 × 10−21 | Yes |
Crazy paving | 44% [799] | 2.72 (1.98, 3.74) | 6.48 × 10−10 | 40% [140] | 2.37 (1.10, 5.11) | 2.72 × 10−02 | 9.94 × 10−11 | Yes |
Peripheral distribution | 63% [749] | 0.52 (0.38, 0.72) | 7.84 × 10−05 | 32% [137] | 0.55 (0.23, 1.31) | 1.77 × 10−01 | 3.73 × 10−05 | Yes |
Predominance inferior | 40% [732] | 1.46 (1.06, 2.02) | 2.13 × 10−02 | 43% [136] | 0.90 (0.42, 1.93) | 7.81 × 10−01 | 2.65 × 10−02 | |
GGO | 91% [824] | 1.72 (0.94, 3.17) | 8.02 × 10−02 | 76% [140] | 1.55 (0.60, 3.98) | 3.66 × 10−01 | 6.01 × 10−02 | |
Consolidation | 69% [773] | 1.36 (0.95, 1.94) | 9.23 × 10−02 | 39% [140] | 1.13 (0.53, 2.41) | 7.56 × 10−01 | 8.69 × 10−02 | |
GGO rounded | 15% [750] | 0.64 (0.40, 1.03) | 6.63 × 10−02 | 7.5% [107] | 3.10 (0.65, 14.75) | 1.56 × 10−01 | 1.18 × 10−01 | |
Consolidation rounded | 17& [535] | 1.08 (0.66, 1.77) | 7.59 × 10−01 | 18% [55] | 0.92 (0.21, 4.09) | 9.11 × 10−01 | 7.77 × 10−01 | |
Other radiological patterns | ||||||||
Cardiomegaly | 25% [115] | 2.84 (1.19, 6.80) | 1.89 × 10−02 | 23% [78] | 0.77 (0.22, 2.72) | 7.40 × 10−01 | 2.42 × 10−02 | |
Splenomegaly | 2.6% [115] | 4.11 (0.36, 46.85) | 2.55 × 10−01 | 10% [78] | 17.33 (1.88, 160) | 1.40 × 10−02 | 1.22 × 10−01 | |
Hepatomegaly | 8.7% [115] | 1.35 (0.36, 5.12) | 6.56 × 10−01 | 18% [78] | 5.17 (1.41, 18.99) | 2.02 × 10−02 | 4.00 × 10−01 | |
COVID treatment | ||||||||
Corticoid | 1.0% [837] | 4.7% [150] | ||||||
Hydroxychloroquine | 4.1% [837] | 34% [150] | ||||||
Immunomodulator | 2.5% [837] | 0% [144] | ||||||
Kaletra | 1.4% [837] | 2.0% [150] | ||||||
Anti-IL6 | 3.2% [837] | 4.7% [150] | ||||||
Interferon | 0.6% [837] | 0% [144] | ||||||